Cargando…

GSK3β inhibition blocks melanoma cell/host interactions by downregulating N-cadherin expression and decreasing FAK phosphorylation

This study addresses the role of glycogen synthase kinase (GSK)-3β signaling in the tumorigenic behavior of melanoma. Immunohistochemical staining revealed GSK3β to be focally expressed in the invasive portions of 12% and 33% of primary and metastatic melanomas, respectively. GSK3 inhibitors and siR...

Descripción completa

Detalles Bibliográficos
Autores principales:	John, Jobin K., Paraiso, Kim H.T., Rebecca, Vito W., Cantini, Liliana P., Abel, Ethan V., Pagano, Nicholas, Meggers, Eric, Mathew, Rahel, Krepler, Clemens, Izumi, Victoria, Fang, Bin, Koomen, John M., Messina, Jane L., Herlyn, Meenhard, Smalley, Keiran S. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479306/ https://www.ncbi.nlm.nih.gov/pubmed/22810307 http://dx.doi.org/10.1038/jid.2012.237

Ejemplares similares

Using quantitative proteomic analysis to understand genotype specific intrinsic drug resistance in melanoma
por: Koomen, John M., et al.
Publicado: (2011)

The Anti-Melanoma Activity of Dinaciclib, a Cyclin-Dependent Kinase Inhibitor, Is Dependent on p53 Signaling
por: Desai, Brijal M., et al.
Publicado: (2013)

Pre-clinical modeling of cutaneous melanoma
por: Rebecca, Vito W., et al.
Publicado: (2020)

FAK and paxillin: regulators of N-cadherin adhesion and inhibitors of cell migration?
por: Schaller, Michael D.
Publicado: (2004)

Gene expression profiling of melanoma cells – searching the haystack
por: Brafford, Patricia, et al.
Publicado: (2005)

Narrowing the knowledge gaps for melanoma
por: Slipicevic, Ana, et al.
Publicado: (2012)

Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma
por: Bogenrieder, Thomas, et al.
Publicado: (2002)

TRIM15 and CYLD regulate ERK activation via lysine 63-linked polyubiquitination
por: Zhu, Guixin, et al.
Publicado: (2021)

Why do women with melanoma do better than men?
por: Smalley, Keiran SM
Publicado: (2018)

Src- and confinement-dependent FAK activation causes E-cadherin relaxation and β-catenin activity
por: Gayrard, Charlène, et al.
Publicado: (2018)

The Role of E-Cadherin and microRNA on FAK Inhibitor Response in Malignant Pleural Mesothelioma (MPM)
por: Yuen, Man Lee, et al.
Publicado: (2021)

Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells
por: Fedorenko, Inna V., et al.
Publicado: (2015)

Metabolomics of primary cutaneous melanoma and matched adjacent extratumoral microenvironment
por: Taylor, Nicholas J., et al.
Publicado: (2020)

Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy
por: Paraiso, K H T, et al.
Publicado: (2010)

The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression
por: Li, Ling, et al.
Publicado: (2011)

From cancer stem cells to tumor maintenance in melanoma
por: Fukunaga-Kalabis, Mizuho, et al.
Publicado: (2011)

Challenges in the humanized mouse model for cancer: A commentary
por: Ramirez-Salazar, Eric, et al.
Publicado: (2021)

PIM kinases as therapeutic targets against advanced melanoma
por: Shannan, Batool, et al.
Publicado: (2016)

Shikonin inhibits the proliferation of cervical cancer cells via FAK/AKT/GSK3β signalling
por: Xu, Ziyan, et al.
Publicado: (2022)

Curcumin Suppresses Metastasis via Sp-1, FAK Inhibition, and E-Cadherin Upregulation in Colorectal Cancer
por: Chen, Chun-Chieh, et al.
Publicado: (2013)

Matricellular Proteins Produced by Melanocytes and Melanomas: In Search for Functions
por: Fukunaga-Kalabis, Mizuho, et al.
Publicado: (2008)

Autophagy Paradox: Strategizing Treatment Modality in Melanoma
por: Pangilinan, Christian, et al.
Publicado: (2023)

FAK/PYK2 promotes the Wnt/β-catenin pathway and intestinal tumorigenesis by phosphorylating GSK3β
por: Gao, Chenxi, et al.
Publicado: (2015)

N-Cadherin Induction by ECM Stiffness and FAK Overrides the Spreading Requirement for Proliferation of Vascular Smooth Muscle Cells
por: Mui, Keeley L., et al.
Publicado: (2015)

E-cadherin, actin, microtubules and FAK dominate different spheroid formation phases and important elements of tissue integrity
por: Smyrek, I., et al.
Publicado: (2018)

Functional Profiling of Live Melanoma Samples Using a Novel Automated Platform
por: Schayowitz, Adam, et al.
Publicado: (2012)

Immunotargeting of tumor subpopulations in melanoma patients: A paradigm shift in therapy approaches
por: Maurer, Margarita, et al.
Publicado: (2012)

Combining DNA Damage Induction with BCL-2 Inhibition to Enhance Merkel Cell Carcinoma Cytotoxicity
por: Liu, Wei, et al.
Publicado: (2020)

Inhibition of BRAF and BRAF+MEK drives a metastatic switch in melanoma
por: Smalley, Keiran SM, et al.
Publicado: (2015)

Histone deacetylase inhibitors: a promising partner for MEK inhibitors in uveal melanoma?
por: Faião-Flores, Fernanda, et al.
Publicado: (2019)

The Bacterial Protein Azurin Impairs Invasion and FAK/Src Signaling in P-Cadherin-Overexpressing Breast Cancer Cell Models
por: Bernardes, Nuno, et al.
Publicado: (2013)

Expression analysis of E-cadherin, Slug and GSK3β in invasive ductal carcinoma of breast
por: Prasad, Chandra P, et al.
Publicado: (2009)

BRAF inhibition generates a host/tumor niche that mediates therapeutic escape
por: Fedorenko, Inna V., et al.
Publicado: (2015)

The macrophage: Switches from a passenger to a driver during anticancer therapy
por: Wang, Tao, et al.
Publicado: (2015)

K27-linked ubiquitination of BRAF by ITCH engages cytokine response to maintain MEK-ERK signaling
por: Yin, Qing, et al.
Publicado: (2019)

The complexity of microenvironment-mediated drug resistance
por: Fedorenko, Inna V., et al.
Publicado: (2015)

Antimelanoma CTL recognizes peptides derived from an ORF transcribed from the antisense strand of the 3′ untranslated region of TRIT1
por: Swoboda, Rolf K, et al.
Publicado: (2015)

Backtracking on FAK
por: Leslie, Mitch
Publicado: (2008)

FAK monitoring
por: Metzmacher, K D
Publicado: (1974)

23. RETROSPECTIVE REVIEW OF ADULT PATIENTS WITH LEPTOMENINGEAL DISEASE SECONDARY TO MELANOMA AT MOFFITT CANCER CENTER: DIAGNOSIS, TREATMENT AND OUTCOMES
por: Pina, Yolanda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_va99dq1e3112c4jm96lv5gbifr